Feasibility of Using Bortezomib With or Without Chemotherapy in Patients With Atypical Teratoid/Rhabdoid Tumors

Clinical trial NCT06853080 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06853080
Sponsor: Taipei Medical University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Teratoid/Rhabdoid Tumors (AT/RTs)Central Nervous System (CNS) Tumors

Start date: 2020-12-02
Primary completion: 2023-12-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.